Clinical Trial Update: Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract Syndrome [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase III, double-blind, placebo-controlled trial of tamsulosin in female patients with lower urinary tract symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Symptoms
• Lower Urinary Tract Syndrome

Drugs mentioned

• Tamsulosin (tamsulosin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Urinary Tract Diseases | Phase 3 | Status: COMPLETED